Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: A histological study on biopsies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Translational Medicine 9.102 (2011)
- Schlagwort
-
-
Zahnprothetik
Zahntechnik
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2012
- Beteiligte Personen und Organisationen
-
Wehrhan, Falk
Hyckel, Peter
Guentsch, Arndt
Nkenke, Emeka
Stockmann, Phillip
Schlegel, Karl A.
Neukam, Friedrich W.
Amann, Kerstin
- URN
-
urn:nbn:de:bvb:29-opus-36643
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wehrhan, Falk
- Hyckel, Peter
- Guentsch, Arndt
- Nkenke, Emeka
- Stockmann, Phillip
- Schlegel, Karl A.
- Neukam, Friedrich W.
- Amann, Kerstin
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2012
Ähnliche Objekte (12)
Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: A histological study on biopsies
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: A histological study on biopsies
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: A histological study on biopsies
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report